Levonorgestrel intrauterine system for heavy menstrual bleeding: a real-world experience from a tertiary centre in Northern India

Authors

  • Meenakshi Thakur Department of Obstetrics and Gynecology, Dr Rajendra Prasad Government Medical College, Kangra, Himachal Pradesh, India
  • Amit Gupta Department of Obstetrics and Gynecology, Dr Rajendra Prasad Government Medical College, Kangra, Himachal Pradesh, India
  • Meenakshi Verma Department of Obstetrics and Gynecology, Dr Rajendra Prasad Government Medical College, Kangra, Himachal Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20253099

Keywords:

Fetal distress, Hypertension in pregnancy, Stillbirths

Abstract

Background: Heavy menstrual bleeding (HMB) affects quality of life and health in reproductive-age women. Levonorgestrel intrauterine system (LNG-IUS) offers a conservative treatment option. This study aimed to evaluate the clinical efficacy and acceptability of LNG-IUS in women with HMB.

Methods: Retrospective analysis of 63 women (32-50 years) with HMB at Dr. RPGMC, Kangra, over two years. Follow-up was conducted at 1, 3, 6, and 12 months. Data included demographics, clinical presentation, hematological investigations, ultrasonographic findings, follow-up outcomes, and patient satisfaction scores.

Results: Mean age was 44.28 years; 50.79% were 45-50 years. Majority (68.25%) were para 2; 96.82% were married. Socioeconomic status varied, with 25.39% in the upper-lower class. The most common diagnosis was dysfunctional uterine bleeding (57.14%), followed by fibroid uterus (25.39%), adenomyosis (11.11%), and endometriosis (6.34%). Comorbidities included hypertension (15.87%) and diabetes (11.11%). Hemoglobin analysis showed moderate anemia in 52.38% and severe anemia in 26.98%. Bleeding patterns improved significantly: at 1 month, 57.14% had scanty flow; by 3 months, 74.60% reported reduced bleeding; at 6 months, 86.27% had scanty or no bleeding. By 12 months, 41.17% developed amenorrhea. Expulsion occurred in 2 cases; 2 others requested removal. Overall, 82.35% were satisfied with bleeding pattern; 98.03% had no dysmenorrhea. Social, sexual life, and mobility improved notably. Satisfaction assessment showed 80.38% of patients were either satisfied or very satisfied.

Conclusions: LNG-IUS is effective, safe, and well accepted for treating HMB, particularly in resource-limited settings. Its impact on reducing blood loss, correcting anemia, and improving life quality supports its wider use.

Metrics

Metrics Loading ...

References

Kaur H, Sikka P, Kaur T. Efficacy of LNG-IUS in heavy menstrual bleeding: a cohort study. Int J Reprod Contracept Obstet Gynecol. 2021;10(2):456-60. DOI: https://doi.org/10.18203/2320-1770.ijrcog20211417

Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods. Am J Obstet Gynecol. 2004;190(5):1216-23. DOI: https://doi.org/10.1016/j.ajog.2003.11.015

Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw. 1971;78:933-9. DOI: https://doi.org/10.1111/j.1471-0528.1971.tb00208.x

Janssen CA, Scholten PC, Heintz AP. Reconsidering menorrhagia in gynecological practice. Eur J Obstet Gynecol Reprod Biol. 1998;78:69-72. DOI: https://doi.org/10.1016/S0301-2115(97)00275-3

Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivelä A, et al. Clinical outcomes and costs with LNG-IUS or hysterectomy for menorrhagia: RCT 5-year follow-up. JAMA. 2004;291(12):1456-63. DOI: https://doi.org/10.1001/jama.291.12.1456

Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification (PALM-COEIN) for AUB. Int J Gynaecol Obstet. 2011;113(1):3-13. DOI: https://doi.org/10.1016/j.ijgo.2010.11.011

Kaunitz AM, Bissonnette F, Monteiro I. LNG-IUS vs medroxyprogesterone for HMB: RCT. Practice Bulletin No. 115: Vaginal Birth After Previous Cesarean Delivery. Obstet Gynecol. 2010;116(3):625-32. DOI: https://doi.org/10.1097/AOG.0b013e3181eeb251

Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L. LNG-IUS vs endometrial ablation in HMB: systematic review & meta-analysis. Obstet Gynecol. 2009;113(5):1104-16. DOI: https://doi.org/10.1097/AOG.0b013e3181a1d3ce

Kucuk T, Ertan K. Medroxyprogesterone acetate vs LNG-IUS in perimenopausal menorrhagia: RCT. Clin Exp Obstet Gynecol. 2008;35:57-60.

Senol T, Kahramanoglu I, Dogan Y, Baktiroglu M, Karateke A, Suer N. Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma. Clin Exp Obstet Gynecol. 2015;42(2):224-7. DOI: https://doi.org/10.12891/ceog1826.2015

Awasthi D, Kulshrestha V, Agarwal N. Efficacy of LNG-IUS in uterine leiomyoma. Int J Gynaecol Obstet. 2012;116(1):35-8. DOI: https://doi.org/10.1016/j.ijgo.2011.07.031

Sheng J, Zhang WY, Zhang JP, Lu D. LNG-IUS study on adenomyosis: 3-year follow-up. Contraception. 2009;79(3):189-93. DOI: https://doi.org/10.1016/j.contraception.2008.11.004

ockhat FB, Emembolu JO, Konje JC. Effectiveness of LNG-IUS in endometriosis. Hum Reprod. 2005;20(3):789-93. DOI: https://doi.org/10.1093/humrep/deh650

Tariq N, Ayub R, Jaffery T, Khan AT. Efficacy of LNG-IUS for AUB & contraception. J Coll Physicians Surg Pak. 2011;21(4):210-3.

Paula HB, Jeffrey TJ. LNG-IUS use: contraceptive & non-contraceptive benefits. Int J Womens Health. 2009;1:45-58.

Gorgen H, Api M, Akça A, Cetin A. Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Arch Gynecol Obstetr. 2009;279(6):835-40. DOI: https://doi.org/10.1007/s00404-008-0834-x

Lete I, Obispo C, Izaguirre F, Orte T, Rivero B, Cornellana MJ, Bermejo I, et al. The levonorgestrel intrauterine system (Mirena®) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction. The Europ J Contracep Reproduct Health Care. 2008;13(3):231-7. DOI: https://doi.org/10.1080/13625180802075075

Chen X, Liu Y, Peng Z. LNG-IUS vs medical therapies for HMB: systematic review & meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022;273:112-8.

Desai RM. LNG-IUS for menorrhagia due to benign uterine lesions in perimenopausal women. J Midlife Health. 2012;3(1):20-3. DOI: https://doi.org/10.4103/0976-7800.98812

Downloads

Published

2025-09-26

How to Cite

Thakur, M., Gupta, A., & Verma, M. (2025). Levonorgestrel intrauterine system for heavy menstrual bleeding: a real-world experience from a tertiary centre in Northern India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(10), 3502–3506. https://doi.org/10.18203/2320-1770.ijrcog20253099

Issue

Section

Original Research Articles